Sulkowski M - Search Results

1

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.

Sulkowski M, Pol S, Mallolas J, Fainboim H, Cooper C, Slim J, Rivero A, Mak C, Thompson S, Howe AY, Wenning L, Sklar P, Wahl J, Greaves W; P05411 study investigators. Sulkowski M, et al. Lancet Infect Dis. 2013 Jul;13(7):597-605. doi: 10.1016/S1473-3099(13)70149-X. Epub 2013 Jun 12. Lancet Infect Dis. 2013. PMID: 23768747 Clinical Trial.

2

The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults.

Sulkowski MS, Chaisson RE, Karp CL, Moore RD, Margolick JB, Quinn TC. Sulkowski MS, et al. J Infect Dis. 1998 Dec;178(6):1642-8. doi: 10.1086/314491. J Infect Dis. 1998. PMID: 9815216

3

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.

Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Sulkowski MS, et al. Clin Infect Dis. 2000 Apr;30 Suppl 1:S77-84. doi: 10.1086/313842. Clin Infect Dis. 2000. PMID: 10770916 Review.

4

Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.

Cummings KJ, Lee SM, West ES, Cid-Ruzafa J, Fein SG, Aoki Y, Sulkowski MS, Goodman SN. Cummings KJ, et al. Among authors: sulkowski ms. JAMA. 2001 Jan 10;285(2):193-9. doi: 10.1001/jama.285.2.193. JAMA. 2001. PMID: 11176813 Review.

5

HIV and hepatitis C virus co-infection.

Sulkowski M. Sulkowski M. Hopkins HIV Rep. 1998 Nov;10(6):8, 12. Hopkins HIV Rep. 1998. PMID: 11366132

6

Hepatitis C Virus Infection in HIV-infected Patients.

Sulkowski MS. Sulkowski MS. Curr Infect Dis Rep. 2001 Oct;3(5):469-476. Curr Infect Dis Rep. 2001. PMID: 11559468

7

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

Soriano V, Sulkowski M, Bergin C, Hatzakis A, Cacoub P, Katlama C, Cargnel A, Mauss S, Dieterich D, Moreno S, Ferrari C, Poynard T, Rockstroh J. Soriano V, et al. Among authors: sulkowski m. AIDS. 2002 Apr 12;16(6):813-28. doi: 10.1097/00002030-200204120-00001. AIDS. 2002. PMID: 11919483 Review. No abstract available.

8

Peginterferon-alpha-2a (40kD) and ribavirin in patients with chronic hepatitis C: a phase II open-label study.

Sulkowski M, Reindollar R, Thomas DL, Brinkley-Laughton S, Hudson M, Yu J. Sulkowski M, et al. BioDrugs. 2002;16(2):105-9. doi: 10.2165/00063030-200216020-00004. BioDrugs. 2002. PMID: 11985484 Clinical Trial.

9

Needlestick transmission of hepatitis C.

Sulkowski MS, Ray SC, Thomas DL. Sulkowski MS, et al. JAMA. 2002 May 8;287(18):2406-13. doi: 10.1001/jama.287.18.2406. JAMA. 2002. PMID: 11988061

10

Hepatitis C and progression of HIV disease.

Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Sulkowski MS, et al. JAMA. 2002 Jul 10;288(2):199-206. doi: 10.1001/jama.288.2.199. JAMA. 2002. PMID: 12095384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

432 results

Search Page